TKG Therapeutics, Inc. is a promising startup in the Pharmaceutical industry, founded in 2022. The company recently raised an impressive ¥150.00M in a Seed Round investment on 31 January 2024. Notably, this funding was backed by industry leaders Real Tech Holdings and Mitsubishi Gas Chemical.
TKG Therapeutics, Inc.
Founded 2022
2 employees
Seed
Total: $150.00M
Life Sciences, Pharmaceutical
General Information
Company Name
TKG Therapeutics, Inc.
Founded Year
2022
Employees
2
Industries
Life Sciences, Pharmaceutical
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with TKG Therapeutics, Inc.. To contact TKG Therapeutics, Inc., visit tkg-na.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Life Sciences
About TKG Therapeutics, Inc.
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | Undisclosed | 1 |
|
31 Jan 2024 |
| Seed Round | ¥150.00M | 2 |
|
31 Jan 2024 |
FAQ About TKG Therapeutics, Inc.
TKG Therapeutics, Inc. was founded in 2022.
TKG Therapeutics, Inc. operates in Life Sciences and Pharmaceutical.
TKG Therapeutics, Inc. has approximately 2 employees.
TKG Therapeutics, Inc. has completed 2 funding rounds, raising a total of $150.00M. The latest funding stage is Seed.
We're actively collecting intelligence on TKG Therapeutics, Inc..
Source: BounceWatch company record for TKG Therapeutics, Inc., https://bouncewatch.com/company/tkg-therapeutics-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.
